http://aidsinfo.nih.gov/education-materials/fact-sheets/21/58/fda-approved-hiv-medicines#
| Drug Class | Generic Name (Other names and acronyms) | Brand Name | FDA Approval Date |
|---|---|---|---|
| Nucleoside Reverse Transcriptase Inhibitors (NRTIs) | |||
| NRTIs block reverse transcriptase, anenzyme HIV needs to make copies of itself. | abacavir (abacavir sulfate, ABC) | Ziagen | December 17, 1998 |
| didanosine (ddI, ddI EC) | Videx | October 9, 1991 | |
| Videx EC (enteric-coated) | October 31, 2000 | ||
| emtricitabine (FTC) | Emtriva | July 2, 2003 | |
| lamivudine (3TC) | Epivir | November 17, 1995 | |
| stavudine (d4T) | Zerit | June 24, 1994 | |
| tenofovir disoproxil fumarate (tenofovir DF, TDF) | Viread | October 26, 2001 | |
| zidovudine (azidothymidine, AZT, ZDV) | Retrovir | March 19, 1987 | |
| Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) | |||
| NNRTIs bind to and later alter reverse transcriptase, an enzyme HIV needs to make copies of itself. | delavirdine (delavirdine mesylate, DLV) | Rescriptor | April 4, 1997 |
| efavirenz (EFV) | Sustiva | September 17, 1998 | |
| etravirine (ETR) | Intelence | January 18, 2008 | |
| nevirapine (NVP) | Viramune | June 21, 1996 | |
| Viramune XR (extended release) | March 25, 2011 | ||
| rilpivirine (rilpivirine hydrochloride, RPV) | Edurant | May 20, 2011 | |
| Protease Inhibitors (PIs) | |||
| PIs block HIV protease, an enzyme HIV needs to make copies of itself | atazanavir (atazanavir sulfate, ATV) | Reyataz | June 20, 2003 |
| darunavir (darunavir ethanolate, DRV) | Prezista | June 23, 2006 | |
| fosamprenavir (fosamprenavir calcium, FOS-APV, FPV) | Lexiva | October 20, 2003 | |
| indinavir (indinavir sulfate, IDV) | Crixivan | March 13, 1996 | |
| nelfinavir (nelfinavir mesylate, NFV) | Viracept | March 14, 1997 | |
| ritonavir (RTV) | Norvir | March 1, 1996 | |
| saquinavir (saquinavir mesylate, SQV) | Invirase | December 6, 1995 | |
| tipranavir (TPV) | Aptivus | June 22, 2005 | |
| Fusion Inhibitors | |||
| Fusion inhibitors block HIV from entering theCD4 cells of the immune system. | enfuvirtide (T-20) | Fuzeon | March 13, 2003 |
| Entry Inhibitors | |||
| Entry inhibitors block proteins on the CD4 cells that HIV needs to enter the cells. | maraviroc (MVC) | Selzentry | August 6, 2007 |
| Integrase Inhibitors | |||
| Integrase inhibitors block HIV integrase, an enzyme HIV needs to make copies of itself. | dolutegravir (DTG) | Tivicay | August 13, 2013 |
| elvitegravir (EVG) | Vitekta | September 24, 2014 | |
| raltegravir (raltegravir potassium, RAL) | Isentress | October 12, 2007 | |
| Pharmacokinetic Enhancers | |||
| Pharmacokinetic enhancers are used in HIV treatment to increase the effectiveness of an HIV medicine included in an HIV regimen. | cobicistat (COBI) | Tybost | September 24, 2014 |
| Combination HIV Medicines | |||
| Combination HIV medicines contain two or more HIV medicines from one or more drug classes. | abacavir and lamivudine (abacavir sulfate / lamivudine, ABC / 3TC) | Epzicom | August 2, 2004 |
| abacavir, dolutegravir, and lamivudine (abacavir sulfate / dolutegravir sodium / lamivudine, ABC / DTG / 3TC) | Triumeq | August 22, 2014 | |
| abacavir, lamivudine, and zidovudine (abacavir sulfate / lamivudine / zidovudine, ABC / 3TC / ZDV) | Trizivir | November 14, 2000 | |
| efavirenz, emtricitabine, and tenofovir disoproxil fumarate (efavirenz / emtricitabine / tenofovir, efavirenz / emtricitabine / tenofovir DF, EFV / FTC / TDF) | Atripla | July 12, 2006 | |
| elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate (QUAD, EVG / COBI / FTC / TDF) | Stribild | August 27, 2012 | |
| emtricitabine, rilpivirine, and tenofovir disoproxil fumarate (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate, emtricitabine / rilpivirine / tenofovir, FTC / RPV / TDF) | Complera | August 10, 2011 | |
| emtricitabine and tenofovir disoproxil fumarate (emtricitabine / tenofovir, FTC / TDF) | Truvada | August 2, 2004 | |
| lamivudine and zidovudine (3TC / ZDV) | Combivir | September 27, 1997 | |
| lopinavir and ritonavir (ritonavir-boosted lopinavir, LPV/r, LPV / RTV) | Kaletra | September 15, 2000 | |
No comments:
Post a Comment